Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.8%

2 terminated out of 53 trials

Success Rate

87.5%

+0.9% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (19)
P 1 (3)
P 3 (2)

Trial Status

Recruiting19
Completed14
Unknown11
Active Not Recruiting3
Terminated2
Withdrawn2

Trial Success Rate

87.5%

Benchmark: 86.6%

Based on 14 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT06276764Enrolling By Invitation

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

NCT03334708Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

NCT05873699Phase 1RecruitingPrimary

Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

NCT06320990Phase 1RecruitingPrimary

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

NCT07136324Active Not RecruitingPrimary

Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry

NCT07206355Recruiting

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT05692596Active Not Recruiting

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

NCT03085004Phase 3TerminatedPrimary

CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

NCT02775461Recruiting

Pancreas Registry and High Risk Registry

NCT04275557Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

NCT06305728RecruitingPrimary

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

NCT04291651RecruitingPrimary

UCSF PANC Cyst Registry

NCT07173257Recruiting

PROMs After Pancreatectomy

NCT06939023Not ApplicableRecruiting

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

NCT03492151RecruitingPrimary

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

NCT05334836Not ApplicableRecruiting

Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features

NCT06564571Recruiting

Artificial Intelligence in Endoscopic Ultrasound

NCT03260842RecruitingPrimary

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

NCT06867172Recruiting

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

NCT02422147CompletedPrimary

EUS-guided Ablation of Pancreatic Cyst Neoplasms

Scroll to load more

Research Network

Activity Timeline